Seeing Is Believing
Analyst Chris Cooper, currently employed at GOLDMAN SACHS,
Most recent stock forecast was given on RMD, ResMed at 22-Dec-2024.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 months 26 days ago
(25-Oct-2024)
11/11 (100%)
$-8.75 (-3.58%)
211
Buy
$270
$32.73 (13.79%)
$220
2 months 25 days ago
(26-Sep-2024)
7/9 (77.78%)
$27.44 (11.31%)
154
Hold
$200
5 months 26 days ago
(25-Jun-2024)
7/12 (58.33%)
$-17.58 (-8.08%)
84
Buy
$215
$-22.27 (-9.39%)
$215
8 months 24 days ago
(27-Mar-2024)
10/11 (90.91%)
$19.11 (9.76%)
114
$164
$-73.27 (-30.88%)
$158
10 months 26 days ago
(25-Jan-2024)
5/6 (83.33%)
$-21.47 (-11.58%)
162